A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
Open Access
- 19 March 2014
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2014, 1-22
Abstract
PET based tools can improve the early diagnosis of Alzheimers disease (AD) and differential diagnosis of dementia. The importance of identifying individuals at risk of developing dementia among people with subjective cognitive complaints or mild cognitive impairment has clinical, social, and therapeutic implications. Within the two major classes of AD biomarkers currently identified, that is, markers of pathology and neurodegeneration, amyloid- and FDG-PET imaging represent decisive tools for their measurement. As a consequence, the PET tools have been recognized to be of crucial value in the recent guidelines for the early diagnosis of AD and other dementia conditions. The references based recommendations, however, include large PET imaging literature based on visual methods that greatly reduces sensitivity and specificity and lacks a clear cut-off between normal and pathological findings. PET imaging can be assessed using parametric or voxel-wise analyses by comparing the subjects scan with a normative data set, significantly increasing the diagnostic accuracy. This paper is a survey of the relevant literature on FDG and amyloid-PET imaging aimed at providing the value of quantification for the early and differential diagnosis of AD. This allowed a meta-analysis and GRADE analysis revealing high values for PET imaging that might be useful in considering recommendations.Keywords
This publication has 134 references indexed in Scilit:
- A European multicentre PET study of fibrillar amyloid in Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevantNeuroImage, 2012
- Inter-rater reliability of manual and automated region-of-interest delineation for PiB PETNeuroImage, 2011
- Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI populationNeuroImage, 2011
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal FluidBiological Psychiatry, 2009
- Amyloid imaging in mild cognitive impairment subtypesAnnals of Neurology, 2009
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer DiseaseArchives of Neurology, 2009
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004